Medications

Buprenorphine use remained stable during first year of pandemic

The number of active prescriptions for the opioid disorder treatment drug buprenorphine remained constant during the first year of the COVID-19 pandemic, but the number of new prescriptions for the treatment was far below ...

Medications

Suvorexant may ease symptoms during opioid withdrawal therapy

For individuals with opioid use disorder undergoing a buprenorphine/naloxone taper, suvorexant might be a promising treatment for reducing sleep disturbance and easing opioid withdrawal, according to a study published online ...

page 1 from 4